Evidence map›Paper›PMID 35490452›Full record

ArticleCytokine2022

Cytokine response over the course of COVID-19 infection in pregnant women.

Daniel B Rosen, Elisabeth A Murphy, Ron S Gejman, Allyson Capili, Rachel L Friedlander, Sophie Rand, Kristen A Cagino, Shannon M Glynn, Kathy C Matthews, Jeff M Kubiak and 4 more

Open access · greenAbstract read
In one paragraph

Article in Cytokine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Daniel B RosenWeill Cornell Medicine, New York, NY, USA.
Elisabeth A MurphyDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Ron S GejmanWeill Cornell Medicine, New York, NY, USA.
Allyson CapiliWeill Cornell Medicine, New York, NY, USA.
Rachel L FriedlanderWeill Cornell Medicine, New York, NY, USA.
Sophie RandDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Kristen A CaginoDepartment of Obstetrics & Gynecology, Weill Cornell Medicine, New York, NY, USA.
Shannon M GlynnWeill Cornell Medicine, New York, NY, USA.
Kathy C MatthewsDepartment of Obstetrics & Gynecology, Weill Cornell Medicine, New York, NY, USA.
Jeff M KubiakDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Jim YeeNew York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA.
Malavika PrabhuDepartment of Obstetrics & Gynecology, Weill Cornell Medicine, New York, NY, USA.
Laura E RileyDepartment of Obstetrics & Gynecology, Weill Cornell Medicine, New York, NY, USA.
Yawei J YangDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA. Electronic address: yang@med.cornell.edu.
Weill Cornell Medicine · USCornell University · USPresbyterian Hospital · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

objectiveTo study how severity and progression of coronavirus disease (COVID-19) affect cytokine profiles in pregnant women. MATERIALS AND

methods69 third-trimester, pregnant women were tested for COVID-19 infection and SARS-CoV-2 specific IgM and IgG antibodies. Patients were stratified according to SARS-CoV-2 Reverse Transcriptase-PCR (RT-PCR) status and serology (IgM and IgG) status. Cytokines G-CSF, HGF, IL-18, IL-1Ra, IL-2Ra, IL-8, and IP-10 were measured via ELISA. Retrospective chart review for COVID-19 symptoms and patient vitals was conducted, and cytokine levels were compared between SARS-CoV-2 positive and negative cohorts, by seronegative and seropositive infection, by time course since onset of infection, and according to NIH defined clinical severity.

resultsIL-18, IL-1Ra, and IP-10 increased in the 44 RT-PCR positive pregnant women compared to the 25 RT-PCR negative pregnant controls. Elevated cytokine levels were found in early infections, defined by positive RT-PCR and seronegative status, and higher cytokine levels were also associated with more severe disease. By IgM seroconversion, IL-8 and IP-10 returned to levels seen in uninfected patients, while IL-18 levels remained significantly elevated.

conclusionCytokine profiles of third-trimester pregnant women vary with the time course of infection and are correlated with clinical severity.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralChemokine CXCL10CytokinesFemaleHumansImmunoglobulin GImmunoglobulin MInterleukin-18Interleukin 1 Receptor Antagonist ProteinInterleukin-8PregnancyPregnant PeopleRetrospective StudiesAntibodies, ViralChemokine CXCL10CytokinesImmunoglobulin GImmunoglobulin MInterleukin-18Interleukin 1 Receptor Antagonist ProteinInterleukin-8Cytokine profileInterferonInterleukinPregnancySARS-CoV-2

Identifiers

PMID35490452
PMCPMC9035355
OpenAlexW4224325181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.